Editorial: Equity in type 1 diabetes technology and beyond: where are we in 2022?
Front Endocrinol (Lausanne)
.
2024 Mar 26:15:1400240.
doi: 10.3389/fendo.2024.1400240.
eCollection 2024.
Authors
Marie-Anne Burckhardt
1
2
,
Ananta Addala
3
4
,
Martin de Bock
5
Affiliations
1
Pediatric Endocrinology and Diabetology, University Children's Hospital, Basel, Switzerland.
2
Department of Clinical Research, University of Basel, Basel, Switzerland.
3
Division of Endocrinology, Department of Pediatrics, Stanford University, Stanford, CA, United States.
4
Stanford Diabetes Research Center, Stanford University, Stanford, CA, United States.
5
Department of Paediatrics, University of Otago, Christchurch, New Zealand.
PMID:
38596223
PMCID:
PMC11002255
DOI:
10.3389/fendo.2024.1400240
No abstract available
Keywords:
children and adolescents; diabetes technology; disparities; equity; type 1 diabetes.
Publication types
Editorial
MeSH terms
Diabetes Mellitus, Type 1* / therapy
Health Status Disparities
Humans